Binding and interlocking pancreaticojejunostomy vs duct to mucosa pancreaticojejunostomy: A retrospective cohort study

Table 1 Patient demographics and baseline characteristics, n (%)

Preoperative variables	Technique		P value
	DMPJ, n = 34	BIPJ, n = 33
Age, years	62 (57, 70)	66 (59, 73)	0.144
Gender, male	21 (62)	14 (42)	0.158
BMI, kg/m2	23.02 ± 2.89	21.80 ± 3.48	0.124
Hypertension, yes	12 (35)	14 (42)	0.549
Diabetes, yes	7 (21)	5 (15)	0.562
Preoperative biliary drainage, yes	0 (0)	2 (6)	0.239
Neoadjuvant therapy, yes	6 (18)	1 (3)	0.105
White blood cells, × 109/L	6.70 (5.03, 8.03)	6.40 (5.30, 7.60)	0.726
Hemoglobin, g/L	122 ± 24	122 ± 19	0.967
Aspartate aminotransferase, U/L	39 (20, 73)	32 (21, 85)	0.757
Alanine aminotransferase, U/L	33 (22, 60)	36 (24, 101)	0.309
Total bilirubin, μmol/L	15 (10, 64)	19 (13, 159)	0.229
Direct bilirubin, μmol/L	3 (2, 18)	2 (0, 88)	0.591
Blood creatinine, μmol/L	69 (57, 80)	61 (55, 72)	0.185
Blood urea nitrogen, mmol/L	4.39 (3.60, 5.95)	4.36 (3.35, 5.44)	0.580
Serum albumin, g/L	39.0 ± 4.4	36.9 ± 4.4	0.089
C-reactive protein	6.1 (2.5, 33.7)	7.7 (2.9, 25.8)	0.763

DMPJ: Duct to mucosa pancreaticojejunostomy; BIPJ: Binding and interlocking pancreaticojejunostomy; BMI: Body mass index.